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background: Mechanical circulatory support (MCS) is a widely available treatment option for patients with end-stage heart failure. Sex differences 
have been described in patients undergoing many cardiac procedures; however, no studies describe sex differences in both extracorporeal and 
durable MCS. We analyzed sex-related differences of in-hospital outcomes for extracorporeal and durable MCS devices using administrative hospital 
data.
Methods: In total, 113,382,748 hospital records from California, New York, and New Jersey between 1995 and 2011 were screened for placement 
of MCS using ICD-9 procedure codes (37.60, 37.65-6). Patient characteristics were quantified using dataset documentation and ICD-9 codes. Major 
adverse events (MAE) were defined as death, major bleeding, stroke, device infection, or mechanical device complication. Differences between men 
and women were compared using the chi-squared test, and associations between patient characteristics and outcomes were determined using 
logistic regression.
results: We reviewed MCS procedures performed from 1995 to 2011 where sex was reported (n=2456/3245; female 28.4%). Baseline 
characteristics were significantly different in women versus men with women generally being older with fewer chronic co-morbidities. Women had 
higher rates of in-hospital mortality (50% vs. 35.9%, p<0.0001) and MAEs (63.8% vs. 50%, p<0.0001) than men, and female gender was associated 
with an 89% higher likelihood of MAE than men when corrected for multivariate predictors (p<0.0001). In-hospital mortality decreased over time 
with for both men and women (10% relative risk reduction/year, p<0.0001), but mortality in women was higher than men throughout the study 
period.
conclusion: There are significant sex differences in patients receiving MCS. Women had higher in-hospital mortality even as overall mortality 
decreased and were at increased risk of adverse events that was not explained by age or comorbid conditions. Further research on the causes of 
these disproportionate outcomes is needed.
